From: Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
Mutant Gene | Cells/ tissues | Myoclonus & Seizures | Autofluorescent inclusions | Elevated lysosomal pH | ER Stress | Dysregulated degradation | Cellular dysfunction |
---|---|---|---|---|---|---|---|
CLN1 | Ubiquitously expressed, CNS, brain | X | X | X | X | X | protein response |
CLN2 | Ubiquitously expressed, brain, neurons, cerebrospinal fluid | X | X | Â | Â | X | Endocytic pathway dysfunction |
CLN3 | Ubiquitously expressed, CNS, immune and circulatory systems, iPSC, neural progenitor cells, colorectal cancer cells | X | X | X | X | X | TGN is impaired, localized on the lysosome, cellular proliferation, apoptosis and synaptic transmission |
CLN4 | Ubiquitously expressed, neuronal synapses (1% of total synaptic vesicle-associated proteins) | X (Type A) | X | X | – | – | Type: B manifests movement abnormalities with dementia |
CLN5 | Ubiquitously expressed in human tissue, CNS, peripheral organs and tissues, neurons (ganglionic eminence) and microglia | X | X | X | Â | Â | Endosomal sorting, the stability of sortilin and CIMPR both declines, defective myelination |
CLN6 | Ubiquitously expressed | X | X | Â | X | X | manifest characteristic cholesterol and subunit c of mitochondrial ATP synthase (SCMAS), aberrant biometal metabolism |
CLN7 | Ubiquitously expressed at a very low level, its expression in the liver, heart, and pancreas (markedly higher) | X | X | X | Â | X | loss of CLN7 causes depletion of soluble proteins in the lysosomes impairing reactivation of mTOR |
CLN8 | Ubiquitously expressed, high level expression in cerebral cortex and hippocampus in electrical kindling model of epilepsy | X | X |  | X | X | progressive motor neuron dysfunction and retinal degeneration, lysosomal β-glucosidase deficiency, |
CLN9 | Currently designated as CLN4 | – | – | – | – | – |  |
CLN10 | Ubiquitously expressed, brain | X | X | X | Â | X | CTSD-processing |
CLN11 | Ubiquitously expressed, CNS, neuron, microglia, astrocytes, and endothelial cells | X | X | X | – | – | significantly activated microglia after TBI, the elevated lysosomal biogenesis in activated microglia, which increased cerebrocortical neuron damage, reduces lysosomal biogenesis |
CLN12 | Ubiquitously expressed, ventral midbrain, including substantia nigra (high lever), kidney and skeletal muscle (low level) | X | X | X | – | – | extrapyramidal involvement, oxidative-stress in neuroblastoma cells; dysregulated neurotransmission |
CLN13 | CTSF is expressed at a high level in cerebrocortical, hippocampal and cerebellar neurons | X | X | X | – | – | neurons showed accumulation of eosinophilic granules |
CLN14 | Ubiquitously expressed, cerebrocortical and cerebellar Purkinje cells, pyramidal cell layers of the hippocampus (high levels) | X | X | X | – | – | disrupt KCTD7-Cullin-3 interactions |